Granions de Zinc

Granions de Zinc may be available in the countries listed below.

Ingredient matches for Granions de Zinc

Zinc Gluconate

Zinc Gluconate is reported as an ingredient of Granions de Zinc in the following countries:

• France


• Monaco

International Drug Name Search

Magnesorot

Magnesorot may be available in the countries listed below.

Ingredient matches for Magnesorot

Magnesium Orotate

Magnesium Orotate dihydrate (a derivative of Magnesium Orotate) is reported as an ingredient of Magnesorot in the following countries:

• Germany

International Drug Name Search

Temisartan

Temisartan may be available in the countries listed below.

Ingredient matches for Temisartan

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Temisartan in the following countries:

• Argentina

International Drug Name Search

Reukap

Reukap may be available in the countries listed below.

Ingredient matches for Reukap

Ephedrine

Ephedrine hydrochloride (a derivative of Ephedrine) is reported as an ingredient of Reukap in the following countries:

• Bosnia & Herzegowina

International Drug Name Search

Karbamazepin Nycomed

Karbamazepin Nycomed may be available in the countries listed below.

Ingredient matches for Karbamazepin Nycomed

Carbamazepine

Carbamazepine is reported as an ingredient of Karbamazepin Nycomed in the following countries:

• Latvia

International Drug Name Search

Captopril-50

Captopril-50 may be available in the countries listed below.

Ingredient matches for Captopril-50

Captopril

Captopril is reported as an ingredient of Captopril-50 in the following countries:

• Luxembourg

International Drug Name Search

Razadyne ER

See also: Generic Razadyne

Razadyne ER is a brand name of galantamine, approved by the FDA in the following formulation(s):

RAZADYNE ER (galantamine hydrobromide - capsule, extended release; oral)

• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: April 1, 2005
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[RLD][AB]

Has a generic version of Razadyne ER been approved?

A generic version of Razadyne ER has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Razadyne ER and have been approved by the FDA:

galantamine hydrobromide capsule, extended release; oral

• 
  Manufacturer: BARR
  
  Approval date: September 15, 2008
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]


• 
  Manufacturer: IMPAX LABS
  
  Approval date: May 27, 2009
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: January 24, 2011
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]


• 
  Manufacturer: SUN PHARMA GLOBAL
  
  Approval date: February 2, 2011
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: December 15, 2008
  
  Strength(s): EQ 16MG BASE ^[AB], EQ 24MG BASE ^[AB], EQ 8MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Razadyne ER. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Controlled release galantamine composition
  Patent 7,160,559
  Issued: January 9, 2007
  Inventor(s): McGee; John Paul & Gilis; Paul Marie Victor & De Weer; Marc Maurice Germain & de Condé; Valentin Florent Victor & de Bruijn; Herman Johannes Catherina & Van Dycke; Frederic Anne Rodolf
  Assignee(s): Janssen Pharmaceutica N.V.
  The present invention is concerned with controlled release compositions for oral administration comprising galantamine; and with processes of preparing such controlled release compositions.
  
  Patent expiration dates:
  
  
  • December 20, 2019
    
    ✓ 
    Drug product
  
  

See also...

• Razadyne ER Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Razadyne ER Consumer Information (Cerner Multum)
• Razadyne ER Advanced Consumer Information (Micromedex)
• Galantamine Consumer Information (Wolters Kluwer)
• Galantamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Galantamine Solution Consumer Information (Wolters Kluwer)
• Galantamine Consumer Information (Cerner Multum)
• Galantamine Advanced Consumer Information (Micromedex)
• Galantamine Hydrobromide AHFS DI Monographs (ASHP)